转位蛋白在炎症性肠道疾病中促进中性粒细胞介导的粘膜炎症
Qiong He1, Xiao-Han Wu2, Dong-Lang Jiang3
1Department of General Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
World journal of gastroenterology
|July 31, 2025
概括
转位蛋白 (TSPO) 在炎症性肠病 (IBD) 患者的中性粒细胞中升高,导致肠道炎症. 这一发现表明TSPO是IBD的潜在治疗点.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 炎症性肠道疾病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),是慢性胃肠道疾病,其全球流行率正在增加.
- IBD的确切病因尚不清楚,尽管已知中性粒细胞在IBD的发病过程中起着关键作用.
- 转位蛋白 (TSPO) 是一种参与免疫反应的线粒体蛋白,已成为潜在的炎症标记物,但其在IBD中的作用尚未得到充分研究.
研究的目的:
- 研究TSPO在IBD病原发生中的作用,特别关注其在中性粒细胞中的功能.
- 在人类IBD样本和慢性结肠炎小鼠模型中评估TSPO表达.
- 评估TSPO表达和中性粒细胞功能之间的相关性,包括反应性氧物种 (ROS) 生产和中性粒细胞外陷 (NET) 形成.
主要方法:
- 对基因表达综合数据集 (GSE75214,GSE94648,GSE156776) 的生物信息学分析,以评估IBD患者的TSPO表达.
- 定量实时聚合酶连锁反应 (qRT-PCR) 和免疫组织化学染色以评估人类IBD样本和慢性结肠炎小鼠模型中的TSPO表达.
- 中性粒细胞功能测定 (ROS产生,NET形成) 和正子发射断层扫描-计算机断层扫描 (PET-CT) 成像,以评估TSPO表达及其系统性参与.
主要成果:
- 生物信息学分析显示,IBD患者的肠道粘膜和周围血液中TSPO表达升高,特别是在中性粒细胞中.
- 来自UC和CD患者的中性粒细胞中,TSPO显著上调,与ROS产量增加和NET形成相关.
- 在慢性结肠炎的小鼠模型中,TSPO在结肠中性粒细胞和大脑组织中升级,在炎症的结肠和大脑区域中增强PET-CT吸收,表明系统性参与和神经炎症.
结论:
- 在IBD中,TSPO在中性粒细胞中显著上调,并导致肠道炎症.
- 肠道中TSPO表达率升高表明它有可能成为IBD的治疗点.
- 该研究强调TSPO在IBD的系统性参与,包括神经炎症,以及其作为生物标志物的潜力.
关键词:
克罗恩氏病 克罗恩氏病是什么?表达方式表达方式表达肠-大脑轴 肠-大脑轴炎症性肠病是一种炎症性肠病.肠道炎症是一种肠道炎症.神经炎症是一种神经炎症.作为一个中性粒细胞.阳位子辐射断层扫描-计算机断层扫描.转位蛋白是一种转位蛋白.性结肠炎是一种更多相关视频
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
8.4K
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
16.8K
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
235
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
235
01:30Inflammatory Bowel Disease II: Crohn's Disease
387
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
387
01:38Inflammation
55.2K
Overview
55.2K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
326
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
326
01:29Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
01:06Carrier-Mediated Transport
549
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
549